Suco, Zyra Mie M.
HRN: 22-45-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2023
CEFTRIAXONE 1G (VIAL)
01/08/2023
01/14/2023
IVT
2 G
Once A Day
AGE, T/c Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes